---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Bone resorption inhibitors - bisphosphonates]]"
DrugClassContra: "[[Bone resorption inhibitors - bisphosphonates#Contraindications]]"
DrugClassAdverse: "[[Bone resorption inhibitors - bisphosphonates#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Binosto, Fosamax
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Treatment and prevention of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, osteoporosis in men, [[Paget disease]]
5â€“ 10 mg orally, in daily or (70-mg) weekly doses

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action
- [Farnesyl pyrophosphate synthase](https://go.drugbank.com/drugs/DB00630#BE0000776)
    
    Inhibitor
    
- [Hydroxylapatite](https://go.drugbank.com/drugs/DB00630#BE0004801)
    
    Antagonist

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Abdominal pain, esophageal reflux

### Interactions

`= this.ChemLink+this.file.name`

